Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Install App?
Innovations in Pharmaceutical Technology (IPT)
www.iptonline.com
This is how the Install App dialog will look like once your App goes live.
East Rutherford, NJ – January 18, 2023 – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
“Today, we welcome our new colleagues from Snapdragon to Cambrex,” said Tom Loewald, CEO of Cambrex. “With Snapdragon’s depth of scientific expertise in API process development, I’m certain our customers will see the benefits of this combination and be delighted to work with Snapdragon’s team.”
“I am extremely proud of what our team at Snapdragon has built over the years,” said Matt Bio, CEO of Snapdragon. “With Cambrex, we have found an ideal home for our customers and employees, and I look forward to continued success as part of Cambrex.”
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff.
Cambrex continues to expand its portfolio of specialized solutions for pharmaceutical development and manufacturing, with Snapdragon bolstering its depth of expertise in continuous flow manufacturing and complementing recent investments in continuous flow process development capabilities at its High Point, North Carolina facility.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,300 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/7858e175-5796-4661-97c5-764e4186ea1e.png?optimizer=image&width=360&aspect_ratio=3:4)
Avacta acquires Coris Bioconcept, gaining a broad range of marketed professional-use rapid tests
1 June 2023 -- London and Wetherby, UK -- Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that it has acquired Coris Bioconcept SRL for an upfront cash consideration of £7.4m (on a debt-free/cash-free basis and subject to customary working capital adjustments), with an earnout based on future business performance, payable in cash, of up to £3m.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/b46369fa-759e-41cb-b184-d05ded988c77.png?optimizer=image&width=360&aspect_ratio=3:4)
Cellular Origins launches Constellation, a robotic platform enabling scalable therapies manufacture
31 May 2023 -- Cambridge, UK -- Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies (CGTs), has today announced the launch of Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/08330a3a-870b-4752-bc12-271904e35e88.png?optimizer=image&width=360&aspect_ratio=3:4)
Qlucore presents promising results in the field of lung cancer diagnosis
30 May 2023 -- Lund, Sweden -- Qlucore can now present the first results from an EU-funded project for the improved diagnosis of lung cancer. The new classification model not only separates different subgroups of primary lung cancer but also indicates whether the tumour sample is a metastasis of breast, colorectal or kidney cell cancer. This information can have significant implications for treatment decisions in future clinical applications.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/ec4596b6-cc02-4c93-8bb1-66ceb94fbddd.png?optimizer=image&width=360&aspect_ratio=3:4)
Automata launches LINQ Cloud software to scale and manage lab automation from anywhere
24 May 2023 -- London, UK -- Automata, a leading company powering life science labs to fully automate their workflows, today launches LINQ Cloud: cutting-edge laboratory automation software. LINQ Cloud connects a lab’s physical and digital environment together, enabling life science organisations to scale while reducing the manual workload for scientists.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/18bff7dd-0e97-4096-8867-aa9304b4bbe2.png?optimizer=image&width=360&aspect_ratio=3:4)
Enhanced user experience with the latest release of Scitara’s iPaaS for science, now SOC2 certified
24 May 2023 -- Massachusetts, US -- Laboratory digital transformation pioneer, Scitara, announces new releases to its SOC 2-certified Digital Lab Exchange DLX cloud platform to improve the user experience, enhance instrument connectivity and deliver new automation to the lab.
1
Human-Centred Design: From Inception to Integration
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
2
The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
3
Providing Support Throughout the Patient Journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
